News | October 17, 2006

Hayes Inc., an independent health technology assessment company, has completed a comprehensive comparison of five gadolinium-based contrast media for magnetic resonance imaging (MRI) applications. The report provides an evidence-based assessment of the diagnostic performance and comparative safety profiles of MultiHance vs. Magnevist, Omniscan, OptiMARK and ProHance.
The comparison found that MultiHance (gadobenate dimeglumine) exhibits a higher relaxivity in plasma, which may provide better image quality and diagnostic performance than other gadolinium-based contrast agents for certain organs, including the central nervous system, liver, kidneys and breasts.


Additional Content

News | Magnetic Resonance Imaging (MRI)

January 15, 2024 — MRI simulation software leader ScanLabMR announced the release of UltraLab, a breakthrough software ...

Time January 15, 2024
arrow
News | HIMSS

July 1, 2021 — If you are traveling to HIMSS21 in August, be sure to note that the Healthcare Information and Management ...

Time July 01, 2021
arrow
News | Information Technology

April 16, 2021 — The U.S. Food and Drug Administration (FDA) issued the final rule: Medical Device Classification ...

Time April 16, 2021
arrow
News | Enterprise Imaging

February 18, 2021 – Enterprise imaging systems provider Intelerad Medical Systems announced it has acquired Lumedx, a ...

Time February 18, 2021
arrow
News | Analytics Software

May 21, 2020 — Hologic, Inc. announced that Unifi EQUIP, an automated solution that facilitates compliance with the FDA ...

Time May 21, 2020
arrow
Subscribe Now